幽门螺旋杆菌根除失败的影响因素分析

袁龙良; 辛毅; 王启之; 袁龙良; 辛毅; 王启之

doi:10.13898/j.cnki.issn.1000-2200.2019.11.017

[1]

GONI E, FRANCESCHI F.Helicobacter pylori and extragastric diseases[J]. Helicobacter, 2016, 21(1):45.

[2]

LIU Z, ZHAO Y, DONG Y, et al.Effects of helicobacter pylori infection on atherosclerosis with hypertension and type2 diabetes mellitus in AGED population[J]. J Hypertens, 2016, 34(1):e72.

[3]

NISHIZAWA T, SUZUKI H.Mechanisms of Helicobacter pylori antibiotic resistance and molecular testing[J]. Gastrointest Endosc, 2014, 1(19):3389.

[4]

BESPALOV V, SHERBAKOV A, NOVIK V, et al.Conifer green needle complex in patients with precancerous gastric lesions.An observational pilot study[J]. Evid Based Complement Alternat Med, 2016, 2016:3848409.

[5]

LIU J, WANG Y, ZHAO Q, et al.Prevalence and risk factors for Helicobacter pylori infection in southwest China:a study of health examination participants based on 13C-urea breath test[J]. Turk J Med Sci, 2017, 47(5):1456.

[6]

田英, 范旭东, 莫业和等.亚热带沿海地区渔民的抗幽门螺旋杆菌治疗效果分析[J].海南医学, 2015, 26(10):1506.

[7]

SVERDÉN E, BRUSSELAERS N, WAHLIN K, et al.Time latencies of Helicobacter pylori eradication after peptic ulcer and risk of recurrent ulcer, ulcer adverse events, and gastric cancer:a population-based cohort study[J]. Gastrointest Endosc, 2017, 11(35):1010.

[8]

DE FMNCESCO V, GIOIGIO F, HASSAN C, et al.Worldwide H.pylori antiotic resistance:a systematic review[J]. J Gastrojntestin Liver Dis, 2010, 19(4):409.